Muscular Dystrophies clinical trials at UC Irvine
2 research studies open to eligible people
Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD)
open to eligible people ages 4-65
Limb Girdle Muscular Dystrophy comprise a group of disorders made up of over 30 mutations which share a common phenotype of progressive weakness of the shoulder and hip girdle muscles. While the individual genetic mutations are rare, as a cohort, LGMDs are one of the four most common muscular dystrophies. The overall goal of project 1 is to define the key phenotypes as measured by standard clinical outcome assessments (COAs) for limb girdle muscular dystrophies (LGMD) to hasten therapeutic development.
Irvine, California and other locations
Defining Endpoints in Becker Muscular Dystrophy
open to eligible males ages 8 years and up
This is a 24-month, observational study of 150 participants with Becker muscular dystrophy (BMD)
Orange, California and other locations
Our lead scientists for Muscular Dystrophies research studies include Tahseen Mozaffar, MD.